| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4946b9e1c86392c5a2b74ba659ffd5d3 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195 |
| filingDate |
1991-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e466e955de00c8d2c958d649d48bce45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a3a5bc653c80f28f75a66c50276abd6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54c5ce47dfaa85f6ca155afa1a121090 |
| publicationDate |
1993-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CZ-369291-A3 |
| titleOfInvention |
Lysine salicylate based injection dosage form |
| abstract |
Injectable dosage form for human and veterinary usenwhich contains 100 mg to 200 mg of lysine salicylate per mlnsolution for injection, optionally with an addition of 0.01% to 0.15n% antioxidant. An analgesic is used in clinical practice andnanti-inflammatory effect. |
| priorityDate |
1991-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |